## Anticoagulation Indication in Atrial Fibrillation: The CHA₂DS₂-VASc Threshold ### Guideline-Based Risk Stratification **Key Point:** The **CHA₂DS₂-VASc score threshold** is the single best discriminator for anticoagulation need in AF. Current guidelines recommend anticoagulation based on this score, not on individual structural or hemodynamic findings. ### CHA₂DS₂-VASc Score Interpretation | Score Component | Points | |-----------------|--------| | **C** — Congestive heart failure | 1 | | **H** — Hypertension | 1 | | **A₂** — Age ≥75 years | 2 | | **D** — Diabetes | 1 | | **S₂** — Stroke/TIA/thromboembolism | 2 | | **V** — Vascular disease (MI, PAD, aortic plaque) | 1 | | **A** — Age 65–74 years | 1 | | **Sc** — Sex category (female) | 1 | ### Anticoagulation Thresholds **High-Yield:** - **Males:** CHA₂DS₂-VASc ≥1 → consider anticoagulation; ≥2 → anticoagulation recommended - **Females:** CHA₂DS₂-VASc ≥2 → consider anticoagulation; ≥3 → anticoagulation recommended - **Score 0 (males) or 1 (females):** No anticoagulation unless other high-risk features ### Why This Is the Discriminator The CHA₂DS₂-VASc score **integrates multiple stroke risk factors** into a single validated metric. It is the **only evidence-based tool** that distinguishes low-risk patients (who may not need anticoagulation) from high-risk patients (who do). Individual findings (LA enlargement, reduced EF, prior TIA) are components of the score, not independent decision-makers. **Clinical Pearl:** A patient with CHA₂DS₂-VASc = 0 (male, no comorbidities, age <65) does not need anticoagulation despite having AF. Conversely, a patient with CHA₂DS₂-VASc = 2 needs anticoagulation even if LA size is normal. **Mnemonic:** **CHA₂DS₂-VASc** — **C**ongestive heart failure, **H**ypertension, **A**ge ≥75 (×2), **D**iabetes, **S**troke (×2), **V**ascular disease, **A**ge 65–74, **Sc**ex (female) [cite:Harrison 21e Ch 226]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.